Position in HALO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,924,241
+$11,435,013 QoQ
Shares Held
305,663
+58.2% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#77
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Derivatives in HALO
reported options exposure · as of Jun 30, 2026CallValue
$1,267,974
CallShares
16,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. HALO ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in HALO
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,267,974 | 16,200 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $23,924,241 | 305,663 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,047,006 | 16,200 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $12,489,228 | 193,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,934,216 | 236,764 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $22,605,073 | 308,223 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $15,373,729 | 295,535 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $15,947,266 | 249,918 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $16,733,020 | 349,990 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $17,511,947 | 305,939 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $8,035,426 | 153,465 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $11,576,672 | 284,579 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $15,179,396 | 410,698 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $8,188,246 | 214,352 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $10,129,248 | 280,822 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $7,432,842 | 194,628 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $6,637,612 | 116,654 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,404,201 | 111,386 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,606,484 | 36,511 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,968,985 | 74,448 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,599,993 | 213,877 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,467,432 | 134,401 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $5,827,827 | 128,338 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $10,011,560 | 240,143 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,605,454 | 178,072 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,176,772 | 235,037 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,998,040 | 223,724 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,851,144 | 158,485 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||